Sorrento Cleared For Ch. 11 Loan Over Nant Entity Objection
By Vince Sullivan · February 21, 2023, 7:02 PM EST
Bankrupt pharmaceutical research company Sorrento Therapeutics received interim approval Tuesday for a $75 million Chapter 11 loan after a Texas judge overruled objections from a litigation foe of the debtor's that...
To view the full article, register now.